Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Perspective Therapeutics is a biopharmaceutical company specializing in targeted alpha radiopharmaceuticals for cancer treatment. Its core focus is developing precision therapies using proprietary Lead-212 (212Pb) and Lead-203 (203Pb) isotopes, combined with specialized targeting peptides for cancers like neuroendocrine tumors and melanoma. The company leverages theranostic diagnostics, scalable manufacturing, and a broad pipeline to deliver personalized, effective cancer treatments with minimized toxicity.
This description was generated via AI from an annual report. Updated about 1 year ago.